Gemcitabine or gemcitabine plus cisplatin for in 42 patients with locally advanced or metastatic pancreatic cancer. - Concepedia

Concepedia

Publication | Closed Access

Gemcitabine or gemcitabine plus cisplatin for in 42 patients with locally advanced or metastatic pancreatic cancer.

36

Citations

0

References

2002

Year

Xingyuan Wang, Quanxing Ni, Maolin Jin, Zhaoshen Li, Yuxin Wu, Yu-pei Zhao, Feng-yi Feng

Abstract

GEM or GEM plus CDDP is able to lead to a moderate objective response rate, also significantly improve the quality of life in patients with locally advanced or metastatic pancreatic cancer patients, prolonging the survival time with tolerable toxicity.